Ravi Kurukulasuriya

665 total citations
15 papers, 432 citations indexed

About

Ravi Kurukulasuriya is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Ravi Kurukulasuriya has authored 15 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Ravi Kurukulasuriya's work include Diabetes Treatment and Management (4 papers), Hormonal Regulation and Hypertension (4 papers) and Adrenal and Paraganglionic Tumors (3 papers). Ravi Kurukulasuriya is often cited by papers focused on Diabetes Treatment and Management (4 papers), Hormonal Regulation and Hypertension (4 papers) and Adrenal and Paraganglionic Tumors (3 papers). Ravi Kurukulasuriya collaborates with scholars based in United States and United Kingdom. Ravi Kurukulasuriya's co-authors include Bruce G. Szczepankiewicz, David R. Hill, Steven J. Wittenberger, J. T. Link, David J. Madar, Jon E. Rohde, Andrew J. Souers, Selena E. Richards, Zhili Pei and Jeffrey J. Rohde and has published in prestigious journals such as Organic Letters, Current Medicinal Chemistry and Photochemistry and Photobiology.

In The Last Decade

Ravi Kurukulasuriya

15 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ravi Kurukulasuriya United States	12	240	196	117	50	46	15	432
David J. St. Jean United States	16	425 1.8×	258 1.3×	113 1.0×	45 0.9×	63 1.4×	28	751
Steffen V. F. Hansen Denmark	10	172 0.7×	242 1.2×	95 0.8×	86 1.7×	43 0.9×	12	459
Bernard Hulin United States	15	339 1.4×	307 1.6×	90 0.8×	43 0.9×	46 1.0×	23	645
Daniel Kuzmich United States	12	287 1.2×	111 0.6×	53 0.5×	24 0.5×	35 0.8×	23	527
Martin W. Rowbottom United States	14	231 1.0×	259 1.3×	28 0.2×	16 0.3×	22 0.5×	24	591
Wendy L. Corbett United States	9	363 1.5×	433 2.2×	204 1.7×	373 7.5×	36 0.8×	13	844
Alan M. Birch United Kingdom	11	191 0.8×	165 0.8×	59 0.5×	55 1.1×	18 0.4×	20	402
Béla Tóth Hungary	13	333 1.4×	384 2.0×	60 0.5×	57 1.1×	45 1.0×	27	613
Kenji Negoro Japan	12	225 0.9×	172 0.9×	73 0.6×	48 1.0×	47 1.0×	54	452
Tomoyuki Odani Japan	11	90 0.4×	347 1.8×	215 1.8×	162 3.2×	19 0.4×	14	542

Countries citing papers authored by Ravi Kurukulasuriya

Since Specialization

Citations

This map shows the geographic impact of Ravi Kurukulasuriya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Kurukulasuriya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Kurukulasuriya more than expected).

Fields of papers citing papers by Ravi Kurukulasuriya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Kurukulasuriya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Kurukulasuriya. The network helps show where Ravi Kurukulasuriya may publish in the future.

Co-authorship network of co-authors of Ravi Kurukulasuriya

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Kurukulasuriya. A scholar is included among the top collaborators of Ravi Kurukulasuriya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Kurukulasuriya. Ravi Kurukulasuriya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wilson, Jonathan E., Ravi Kurukulasuriya, Christopher J. Sinz, et al.. (2016). Discovery and development of benzo-[1,2,4]-triazolo-[1,4]-oxazepine GPR142 agonists for the treatment of diabetes. Bioorganic & Medicinal Chemistry Letters. 26(12). 2947–2951. 12 indexed citations

Wilson, Jonathan E., Ravi Kurukulasuriya, Mikhail Reibarkh, et al.. (2016). Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach. ACS Medicinal Chemistry Letters. 7(3). 261–265. 43 indexed citations

Szczepankiewicz, Bruce G. & Ravi Kurukulasuriya. (2007). Aromatic Heterocycle-Based DPP-IV Inhibitors: Xanthines and Related Structural Types.. Current Topics in Medicinal Chemistry. 7(6). 569–578. 9 indexed citations

Kurukulasuriya, Ravi, Jeffrey J. Rohde, Bruce G. Szczepankiewicz, et al.. (2006). Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(24). 6226–6230. 15 indexed citations

Yeh, Vince S. C., Ravi Kurukulasuriya, Steven Fung, et al.. (2006). Synthesis and biological evaluation of heterocycle containing adamantane 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(20). 5414–5419. 18 indexed citations

Yeh, Vince S. C., Ravi Kurukulasuriya, David J. Madar, et al.. (2006). Synthesis and structural activity relationship of 11β-HSD1 inhibitors with novel adamantane replacements. Bioorganic & Medicinal Chemistry Letters. 16(20). 5408–5413. 23 indexed citations

Yeh, Vince S. C., Ravi Kurukulasuriya, Steven Fung, et al.. (2006). Discovery of orally active butyrolactam 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5555–5560. 13 indexed citations

Yeh, Vince S. C., Ravi Kurukulasuriya, & Francis A. J. Kerdesky. (2006). A Highly Efficient Synthesis of Potent and Selective Butyrolactam Inhibitors of 11β-Hsd1. Organic Letters. 8(18). 3963–3966. 4 indexed citations

Kurukulasuriya, Ravi, et al.. (2005). Progress towards glucagon receptor antagonist therapy for Type 2 diabetes. Expert Opinion on Therapeutic Patents. 15(12). 1739–1749. 10 indexed citations

10.

Szczepankiewicz, Bruce G., Jeffrey J. Rohde, & Ravi Kurukulasuriya. (2005). Synthesis of Purines and Other Fused Imidazoles from Acyclic Amidines and Guanidines. Organic Letters. 7(9). 1833–1835. 39 indexed citations

11.

Kurukulasuriya, Ravi, Bryan K. Sorensen, J. T. Link, et al.. (2004). Biaryl amide glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(9). 2047–2050. 21 indexed citations

12.

Kurukulasuriya, Ravi, J. T. Link, David J. Madar, et al.. (2003). Potential Drug Targets and Progress Towards Pharmacologic Inhibition of Hepatic Glucose Production. Current Medicinal Chemistry. 10(2). 123–153. 75 indexed citations

13.

Kurukulasuriya, Ravi, J. T. Link, David J. Madar, et al.. (2003). Prospects for Pharmacologic Inhibition of Hepatic Glucose Production. Current Medicinal Chemistry. 10(2). 99–121. 46 indexed citations

14.

Hill, David R., et al.. (2001). 2,2,2-Trifluoroethyl Formate: A Versatile and Selective Reagent for the Formylation of Alcohols, Amines, andN-Hydroxylamines. Organic Letters. 4(1). 111–113. 90 indexed citations

15.

Morrison, Harry, Taj Mohammad, & Ravi Kurukulasuriya. (1997). Photobiological Properties of Methylene Violet*. Photochemistry and Photobiology. 66(2). 245–252. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact